Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.

O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM.

Gastroenterology. 2005 Mar;128(3):541-51.

PMID:
15765388
2.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.

Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. doi: 10.1016/j.gcb.2007.06.001. Epub 2008 Mar 4.

3.

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.

J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.

PMID:
22157240
4.

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):387-94.

5.

Probiotics in the treatment of irritable bowel syndrome.

Saggioro A.

J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S104-6. Erratum in: J Clin Gastroenterol. 2005 Mar;39(3):261.

PMID:
15220671
6.

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS.

Am J Gastroenterol. 2009 Apr;104(4):1033-49; quiz 1050. doi: 10.1038/ajg.2009.25. Epub 2009 Mar 10. Review.

PMID:
19277023
8.

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.

Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):48-57. Epub 2007 Oct 5.

9.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

10.

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.

Guglielmetti S, Mora D, Gschwender M, Popp K.

Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21.

11.

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.

Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.

J Clin Gastroenterol. 2011 Sep;45(8):679-83. doi: 10.1097/MCG.0b013e318204593e. Erratum in: J Clin Gastroenterol. 2011 Oct;45(9):838.

PMID:
21301358
12.

Review article: probiotics and prebiotics in irritable bowel syndrome.

Spiller R.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):385-96. doi: 10.1111/j.1365-2036.2008.03750.x. Epub 2008 Jun 4. Review.

13.

Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.

Brenner DM, Chey WD.

Rev Gastroenterol Disord. 2009 Winter;9(1):7-15. Review.

PMID:
19367213
14.

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.

Sinn DH, Song JH, Kim HJ, Lee JH, Son HJ, Chang DK, Kim YH, Kim JJ, Rhee JC, Rhee PL.

Dig Dis Sci. 2008 Oct;53(10):2714-8. doi: 10.1007/s10620-007-0196-4. Epub 2008 Feb 15.

PMID:
18274900
15.

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.

Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.

Am J Gastroenterol. 2006 Jul;101(7):1581-90.

PMID:
16863564
16.

Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.

Simrén M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, Strid H.

Aliment Pharmacol Ther. 2010 Jan 15;31(2):218-27. doi: 10.1111/j.1365-2036.2009.04183.x. Epub 2009 Oct 26.

17.

Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.

Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S214-7. doi: 10.1097/MCG.0b013e31817da129. Review.

PMID:
18685517
18.

Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.

Dolin BJ.

Methods Find Exp Clin Pharmacol. 2009 Dec;31(10):655-9. doi: 10.1358/mf.2009.31.10.1441078.

PMID:
20140275
19.

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.

Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):508-18. doi: 10.1111/j.1365-2036.2008.03911.x. Epub 2008 Dec 2.

20.

Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.

Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D; Symbiotic Study Group.

Minerva Gastroenterol Dietol. 2006 Dec;52(4):349-58.

PMID:
17108864

Supplemental Content

Support Center